We are live on ! Find out more
CLPT icon

ClearPoint Neuro

17 hedge funds and large institutions have $3.4M invested in ClearPoint Neuro in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4.79% more ownership

Funds ownership: 0%4.79% (+4.8%)

Holders
17
Holders Change
+17
Holders Change %
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.24M +$1M +244,343 New
Millennium Management
2
Millennium Management
New York
$583K +$472K +115,284 New
MWM
3
Merriman Wealth Management
Washington
$373K +$302K +73,732 New
Bank of America
4
Bank of America
North Carolina
$257K +$208K +50,750 New
KMC
5
Kirr Marbach & Co
Indiana
$219K +$177K +43,200 New
Goldman Sachs
6
Goldman Sachs
New York
$168K +$136K +33,206 New
Brown Advisory
7
Brown Advisory
Maryland
$142K +$115K +28,000 New
PCM
8
Parsons Capital Management
Rhode Island
$135K +$109K +26,623 New
WJWM
9
Williams Jones Wealth Management
New York
$109K +$88.3K +21,552 New
WMC
10
Westwood Management Corporation
Illinois
$89K +$71.7K +17,500 New
Citadel Advisors
11
Citadel Advisors
Florida
$52K +$42.1K +10,268 New
JP Morgan Chase
12
JP Morgan Chase
New York
$15K +$12.3K +3,000 New
Morgan Stanley
13
Morgan Stanley
New York
$8K +$6.37K +1,554 New
AG
14
Advisor Group
Arizona
$7K +$5.33K +1,300 New
OIA
15
Optimum Investment Advisors
Illinois
$2K +$1.79K +437 New
UBS Group
16
UBS Group
Switzerland
$1K +$537 +131 New
Fifth Third Bancorp
17
Fifth Third Bancorp
Ohio
+$205 +50 New

CLPT Hedge Fund Activity: Q3 2019 in Review

17 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2019, worth a combined $3.4M.

Buyers outnumbered sellers: 17 funds opened new CLPT positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $1M.

  • 17 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $3.4M of ClearPoint Neuro stock for Q3 2019.
  • 17 funds opened new ClearPoint Neuro positions in Q3 2019 and 0 closed out, a net change of +17 holders.
  • The largest ClearPoint Neuro buyer in Q3 2019 was Vanguard Group, an estimated $1M added.

Based on aggregated 13F filings for Q3 2019.